Matches in Wikidata for { <http://www.wikidata.org/entity/Q88579691> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q88579691 description "article scientifique publié en 2018" @default.
- Q88579691 description "artículu científicu espublizáu en mayu de 2018" @default.
- Q88579691 description "bài báo khoa học" @default.
- Q88579691 description "im Mai 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q88579691 description "scientific article published on 04 May 2018" @default.
- Q88579691 description "wetenschappelijk artikel" @default.
- Q88579691 description "наукова стаття, опублікована в травні 2018" @default.
- Q88579691 name "Are the favorable cardiovascular outcomes of empagliflozin treatment explained by its effects on multiple cardiometabolic risk factors? A simulation of the results of the EMPA-REG OUTCOME trial" @default.
- Q88579691 name "Are the favorable cardiovascular outcomes of empagliflozin treatment explained by its effects on multiple cardiometabolic risk factors? A simulation of the results of the EMPA-REG OUTCOME trial" @default.
- Q88579691 type Item @default.
- Q88579691 label "Are the favorable cardiovascular outcomes of empagliflozin treatment explained by its effects on multiple cardiometabolic risk factors? A simulation of the results of the EMPA-REG OUTCOME trial" @default.
- Q88579691 label "Are the favorable cardiovascular outcomes of empagliflozin treatment explained by its effects on multiple cardiometabolic risk factors? A simulation of the results of the EMPA-REG OUTCOME trial" @default.
- Q88579691 prefLabel "Are the favorable cardiovascular outcomes of empagliflozin treatment explained by its effects on multiple cardiometabolic risk factors? A simulation of the results of the EMPA-REG OUTCOME trial" @default.
- Q88579691 prefLabel "Are the favorable cardiovascular outcomes of empagliflozin treatment explained by its effects on multiple cardiometabolic risk factors? A simulation of the results of the EMPA-REG OUTCOME trial" @default.
- Q88579691 P1433 Q88579691-69EFD277-A9FB-4AAC-913D-ED91DA2271BC @default.
- Q88579691 P1476 Q88579691-4F7DBC4E-F036-41DF-B3D2-DBF510AFCE02 @default.
- Q88579691 P2093 Q88579691-0BE6AE86-A5D0-48CF-AF2D-EB182696AAE4 @default.
- Q88579691 P2093 Q88579691-7D7A1753-FD21-43E3-A0A5-A0086840C34A @default.
- Q88579691 P2093 Q88579691-7FD8D41F-9593-478E-BF92-A3E832003566 @default.
- Q88579691 P2093 Q88579691-E421CA1D-0C50-41EC-8E43-A5E7F26F86C5 @default.
- Q88579691 P304 Q88579691-85EC5B8F-6388-4C52-BF89-D3CF06269178 @default.
- Q88579691 P31 Q88579691-4227482E-9303-4B66-B75F-B0B3000C1430 @default.
- Q88579691 P356 Q88579691-E61099D9-743F-4A18-81C8-15C516164843 @default.
- Q88579691 P478 Q88579691-BE9508EF-9210-4739-BDA6-02EDDB456139 @default.
- Q88579691 P577 Q88579691-75E84AF9-9224-454A-A37F-57BDEDF5C37A @default.
- Q88579691 P698 Q88579691-999BC868-32B2-4CA2-9D18-5B97CD16AB3B @default.
- Q88579691 P921 Q88579691-EFD5FACA-ADA8-4F1F-9D9C-75B1A99CA287 @default.
- Q88579691 P356 J.DIABRES.2018.04.040 @default.
- Q88579691 P698 29730388 @default.
- Q88579691 P1433 Q15750054 @default.
- Q88579691 P1476 "Are the favorable cardiovascular outcomes of empagliflozin treatment explained by its effects on multiple cardiometabolic risk factors? A simulation of the results of the EMPA-REG OUTCOME trial" @default.
- Q88579691 P2093 "Justin Duong" @default.
- Q88579691 P2093 "Shihchen Kuo" @default.
- Q88579691 P2093 "Wen Ye" @default.
- Q88579691 P2093 "William H Herman" @default.
- Q88579691 P304 "181-189" @default.
- Q88579691 P31 Q13442814 @default.
- Q88579691 P356 "10.1016/J.DIABRES.2018.04.040" @default.
- Q88579691 P478 "141" @default.
- Q88579691 P577 "2018-05-04T00:00:00Z" @default.
- Q88579691 P698 "29730388" @default.
- Q88579691 P921 Q5373824 @default.